Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription


1 Am Heart J
6 Am J Cardiol
1 Am J Med
2 Angiology
1 Ann Thorac Surg
1 Circ Cardiovasc Qual Outcomes
1 Circulation
1 Clin Cardiol
16 Eur Heart J
2 Heart
3 J Am Coll Cardiol
1 J Clin Invest
1 Mayo Clin Proc
1 Mol Cell Biochem
1 PLoS One
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. UDELL JA, Lu D, Bagai A, Dodson JA, et al
    Preexisting Frailty and Outcomes in Older Patients with Acute Myocardial Infarction.
    Am Heart J. 2022 Mar 23. pii: S0002-8703(22)00056.
    PubMed         Abstract available

    Am J Cardiol

  2. ELSADANY M, Thompson PD
    Hyperparathyroidism Possibly Causing Increased Coronary Artery Calcification.
    Am J Cardiol. 2022 Mar 28. pii: S0002-9149(22)00191.

  3. MURUGIAH K, Chen L, Dreyer RP, Bouras G, et al
    Depression and Perceived Stress After Spontaneous Coronary Artery Dissection and Comparison With Other Acute Myocardial Infarction (the VIRGO Experience).
    Am J Cardiol. 2022 Mar 29. pii: S0002-9149(22)00240.
    PubMed         Abstract available

  4. MOHEBI R, Jackson L, McCarthy CP, Murtagh G, et al
    Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction.
    Am J Cardiol. 2022 Mar 28. pii: S0002-9149(22)00237.
    PubMed         Abstract available

  5. GALLONE G, Kang J, Bruno F, Han JK, et al
    Impact of Left Ventricular Ejection Fraction on Procedural and Long-Term Outcomes of Bifurcation Percutaneous Coronary Intervention.
    Am J Cardiol. 2022 Mar 29. pii: S0002-9149(22)00169.
    PubMed         Abstract available

  6. NAEEM H, Khan U, Mohsin M, Niazi K, et al
    Comparison of Invasive Coronary Angiography Versus Computed Tomography Angiography to Assess Mehran Classification of In-Stent Restenosis in Bifurcation Percutaneous Coronary Intervention.
    Am J Cardiol. 2022 Mar 26. pii: S0002-9149(22)00167.
    PubMed         Abstract available

  7. COOK MK, Zhang J, Wei Y
    Blood Lead Levels and Risk of Deaths from Cardiovascular Disease.
    Am J Cardiol. 2022 Mar 26. pii: S0002-9149(22)00255.
    PubMed         Abstract available

    Am J Med

  8. ALPERT JS, Jaffe AS, White HD, Thygesen KA, et al
    Type 1, Type 2 myocardial infarction and non-ischemic myocardial injury-opinion from the front lines.
    Am J Med. 2022 Mar 24. pii: S0002-9343(22)00203.
    PubMed         Abstract available


  9. MANGALESH S, Dudani S
    Neutrophil-to-Lymphocyte Ratio for the Prediction of the Presence and Severity of Coronary Artery Disease.
    Angiology. 2022 Apr 1:33197221087783. doi: 10.1177/00033197221087783.

  10. KESKIN K, Sigirci S, Gurdal A, Ser OS, et al
    In-Hospital Bleeding in Elderly Patients With Acute Coronary Syndrome: Are Potent Antiplatelet Agents Safe?
    Angiology. 2022 Mar 29:33197221075858. doi: 10.1177/00033197221075858.
    PubMed         Abstract available

    Ann Thorac Surg

  11. CHIKWE J
    Editor's Choice: Critical Times for Coronary Revascularization Guidelines.
    Ann Thorac Surg. 2022;113:1061-1064.

    Circ Cardiovasc Qual Outcomes

  12. GULATI G, Upshaw J, Wessler BS, Brazil RJ, et al
    Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models.
    Circ Cardiovasc Qual Outcomes. 2022 Mar 31:101161CIRCOUTCOMES121008487.
    PubMed         Abstract available


  13. BULARGA A, Hung J, Daghem M, Stewart S, et al
    Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
    Circulation. 2022 Mar 28. doi: 10.1161/CIRCULATIONAHA.121.058542.

    Clin Cardiol

  14. MA R, Gao J, Mao S, Wang Z, et al
    Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.
    Clin Cardiol. 2022 Mar 30. doi: 10.1002/clc.23818.
    PubMed         Abstract available

    Eur Heart J

  15. OKA S, Endo H, Takagi K, Yamagata K, et al
    Mechanical coronary artery stenosis induced by active fixation left ventricular lead: a case of acute complication after cardiac resynchronization therapy device implantation.
    Eur Heart J. 2022;43:1271.

  16. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed         Abstract available

  17. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed         Abstract available

  18. SILVAIN J, Hausenloy D, Zeitouni M
    Appropriate criteria for the definition of Type 4a MI.
    Eur Heart J. 2022;43:1013-1014.

  19. NEWBY LK
    A new biomarker of acute coronary ischaemia: from bench to bedside?
    Eur Heart J. 2022;43:164-166.

  20. RYAN M, Morgan H, Chiribiri A, Nagel E, et al
    Myocardial viability testing: all STICHed up, or about to be REVIVED?
    Eur Heart J. 2022;43:118-126.
    PubMed         Abstract available

  21. CREA F
    Hot topics in ischaemic heart disease: revascularization, hibernation, type 2 infarction, and proteomics.
    Eur Heart J. 2022;43:89-92.

  22. TAN S, White HD, Layland J
    Heparin use in acute coronary syndromes and cardiovascular interventions: habit or evidence based?
    Eur Heart J. 2022;43:1008-1011.

  23. CUBEDO J, Padro T, Vilahur G, Crea F, et al
    Glycosylated apolipoprotein J in cardiac ischaemia: molecular processing and circulating levels in patients with acute ischaemic events.
    Eur Heart J. 2022;43:153-163.
    PubMed         Abstract available

  24. QUADRI G, Tomassini F, Cerrato E, Varbella F, et al
    Emergency treatment of a giant coronary aneurysm: percutaneous intervention with coronary and peripheral tools.
    Eur Heart J. 2022;43:168.

  25. DEMIR OM, Rahman H, van de Hoef TP, Escaned J, et al
    Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice.
    Eur Heart J. 2022;43:105-117.
    PubMed         Abstract available

  26. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed         Abstract available

    How to live to 100 before developing clinical coronary artery disease: a suggestion.
    Eur Heart J. 2022;43:249-250.

  28. SLIWICKA O, Damman P, Habets J
    Stress dynamic CT perfusion in the evaluation of acute coronary syndrome.
    Eur Heart J. 2022;43:244.

  29. VAROTTO L, De Boni A, Iannucci G, Caprioglio F, et al
    Uncommon intravascular lithotripsy for the treatment of subclavian steal syndrome: a case presenting with concomitant acute coronary syndrome and transient ischaemic attack.
    Eur Heart J. 2022;43:840.

  30. DE CATERINA R, Liga R, Boden WE
    Myocardial revascularization in ischaemic cardiomyopathy: routine practice vs. scientific evidence.
    Eur Heart J. 2022;43:387-390.


  31. HODGINS P, McMinn M, Shah A, Reed MJ, et al
    Unscheduled care pathways in patients with myocardial infarction in Scotland.
    Heart. 2022 Mar 31. pii: heartjnl-2021-320614. doi: 10.1136/heartjnl-2021-320614
    PubMed         Abstract available

  32. SZE S, Ayton SL, Moss AJ
    Should we always call 911/999 to get it right first time in suspected myocardial infarction?
    Heart. 2022 Mar 31. pii: heartjnl-2022-320918. doi: 10.1136/heartjnl-2022-320918

    J Am Coll Cardiol

  33. KIM TO, Kang DY, Ahn JM, Kim SO, et al
    Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
    J Am Coll Cardiol. 2022;79:1270-1284.
    PubMed         Abstract available

  34. FEGERS-WUSTROW I, Gianos E, Halle M, Yang E, et al
    Comparison of American and European Guidelines for Primary Prevention of Cardiovascular Disease: JACC Guideline Comparison.
    J Am Coll Cardiol. 2022;79:1304-1313.
    PubMed         Abstract available

  35. MIHATOV N, Mosarla RC, Kirtane AJ, Parikh SA, et al
    Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock.
    J Am Coll Cardiol. 2022;79:1223-1235.
    PubMed         Abstract available

    J Clin Invest

  36. HUMERES C, Shinde AV, Hanna A, Alex L, et al
    Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure.
    J Clin Invest. 2022;132.
    PubMed         Abstract available

    Mayo Clin Proc

  37. SARA JDS, Maor E, Orbelo D, Gulati R, et al
    Noninvasive Voice Biomarker Is Associated With Incident Coronary Artery Disease Events at Follow-up.
    Mayo Clin Proc. 2022 Mar 10. pii: S0025-6196(21)00808.
    PubMed         Abstract available

    Mol Cell Biochem

  38. ZHENG Y, Li X, Zhang F, Zhao B, et al
    Protective effect of nicorandil against myocardial ischemia/reperfusion injury mediated via IL33/ST2 signaling pathway.
    Mol Cell Biochem. 2022 Mar 28. pii: 10.1007/s11010-022-04418.
    PubMed         Abstract available

    PLoS One

  39. HU YY, Cai YJ, Jiang X, Mao FY, et al
    Relationship between dynamic changes of peri-procedure anxiety and short-term prognosis in patients undergoing elective percutaneous coronary intervention for coronary heart disease: A single-center, prospective study.
    PLoS One. 2022;17:e0266006.
    PubMed         Abstract available

    Thromb Haemost

  40. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.